Marc Beer

Marc Beer is the recently appointed new chairman of the board at LumeNXT, Inc. This company recognizes Beer’s significant impact on the health industry. He has successfully started up many companies, offering leadership and guidance that gives significant growth results to those specific corporations. He is an experienced and reputed biotechnologist with 25 years of experience in developing and commercializing pharmaceutical and biotechnology devices.

 

Additionally, Beer is the co-founder of Renovia, Inc, a company that enhances restorative and test procedures for women with pelvic-related issues. Situated in the state of Massachusetts, the company’s success is related to its formulation of digital devices for both diagnosis and treatment.

 

He also attributes to the significant contributions of societal well-being. He presently funded the women’s health startup at Renovia, Inc. through the raising of $42M. This company created diagnostic devices for pelvic floor disorders in women, and also therapeutic mechanisms for treating and relieving such-like ailments. The raised funds directed at the development and assessment of other four new products.

 

The co-founder of LumeNXT, Paul Rhyne, says that they are confident of Beer’s excellent contribution towards LumeNXT growth and betterment. He further states that Beer’s significant contributions to the global commercial initiations and further successes are sources of hope for the bright anticipated future of LumeNXT.

 

LumeNXT, Inc. is a private co-owned company that focuses on developing advanced surgical illumination products. Their focus is primarily on minimally invasive surgery. Beer is proud to join the LumeNXT group. He says that he is happy and anticipates working with the great team at LumeNXT. He further describes the group of workers at his newly-joined company as devoted, exceptional, and well-advanced in the surgical illumination sector.

 

Previously, Beer served as the CEO founder of ViaCell, which he joined in April 2000. This biotechnology company collects preserves and develops umbilical cord blood stem cells. Marc Beer’s leadership at ViaCell expanded the company to over 300 employees. It also received high publicity in 2005, before its ultimate acquisition by PerkinElmer in 2007.

 

Before, Beer served top positions at Genzyme, He had worked in different firms where he sharpened his skills and gained invaluable experiences. He was also the vice president at Global Marketing. His principal responsibility at Global Marketing was the launching and commercializing of a line of products which addresses rare illnesses amongst populations and at a global extent.

 

Beer, who was also the chairman of the compensation committee of Good Start Genetics, Inc. says that the minimally invasive surgery adopted by LumeNXT is a safe procedure due to its better visualization. Furthermore, he adds that people are yet to realize the significance of LumeNXT, and especially with the increase of more surgeries that will happen using the minimally invasive technology. Learn more: https://renoviainc.com/leadership/

 

Leave a Reply

Your email address will not be published. Required fields are marked *